{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(5)"],"submitter":["Pils S"],"pubmed_abstract":["<h4>Importance</h4>In addition to treatment efficacy, evaluation of adverse effects and quality of life assessments have become increasingly relevant in oncology.<h4>Objective</h4>To evaluate the association of watching Disney movies during chemotherapy with emotional and social functioning and fatigue status.<h4>Design, setting, and participants</h4>This randomized clinical trial was performed from December 2017 to December 2018 at a cancer referral center in Vienna, Austria. A consecutive sample of women with gynecologic cancers was recruited through July 2018. Inclusion criteria included age older than 18 years, written informed consent, and planned 6 cycles of chemotherapy with either carboplatin and paclitaxel or carboplatin and pegylated liposomal doxorubicin. Exclusion criteria were"],"journal":["JAMA network open"],"pagination":["e204568"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7215261"],"repository":["biostudies-literature"],"pubmed_title":["Effect of Viewing Disney Movies During Chemotherapy on Self-Reported Quality of Life Among Patients With Gynecologic Cancer: A Randomized Clinical Trial."],"pmcid":["PMC7215261"],"pubmed_authors":["Ristl R","Reinthaller A","Steiner E","Ott J","Springer S","Pils S"],"additional_accession":[]},"is_claimable":false,"name":"Effect of Viewing Disney Movies During Chemotherapy on Self-Reported Quality of Life Among Patients With Gynecologic Cancer: A Randomized Clinical Trial.","description":"<h4>Importance</h4>In addition to treatment efficacy, evaluation of adverse effects and quality of life assessments have become increasingly relevant in oncology.<h4>Objective</h4>To evaluate the association of watching Disney movies during chemotherapy with emotional and social functioning and fatigue status.<h4>Design, setting, and participants</h4>This randomized clinical trial was performed from December 2017 to December 2018 at a cancer referral center in Vienna, Austria. A consecutive sample of women with gynecologic cancers was recruited through July 2018. Inclusion criteria included age older than 18 years, written informed consent, and planned 6 cycles of chemotherapy with either carboplatin and paclitaxel or carboplatin and pegylated liposomal doxorubicin. Exclusion criteria were","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 May","modification":"2026-04-14T13:15:34.135Z","creation":"2020-05-22T20:11:03Z"},"accession":"S-EPMC7215261","cross_references":{"pubmed":["32391894"],"doi":["10.1001/jamanetworkopen.2020.4568"]}}